Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CANRENOATE vs CAPLACIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CANRENOATE vs CAPLACIZUMAB: Safety Overview

Metric CANRENOATE CAPLACIZUMAB
Total FAERS Reports 443 145
Deaths Reported 40 34
Death Rate 9.0% 23.4%
Hospitalizations 231 53
Average Patient Age 70.8 yrs 53.0 yrs
% Female Patients 43.5% 51.2%
Manufacturer N/A Genzyme Corporation